Agricultural University of Athens
Μελέτη του παθογενετικού ρόλου του μιτοχονδριακού μεταφορέα SLC25A46 σε ένα γενετικό μοντέλο νευρολογικής νόσου στο ποντίκι
Abstract
dc:descriptionFollowing a forward genetics approach through random mutagenesis with N-ethyl-N-nitrosourea (ENU), Dr. Douni's research group identified a novel mouse model of severe autosomal recessive neurological disease. The symptoms start at 3 weeks of age with full penetrance in both sexes and are characterized by ataxia, unsteady locomotion, episodic crises, failure of limb clasping, reduced body weight and muscle strength and early lethality. Due to the prominent neurological symptoms, the novel mouse model was designated as ataxic. Using genome-wide linkage analysis a nonsense point mutation (C to T) was identified in the coding region of the Slc25a46 gene, a member of the mitochondrial carrier family SLC25 (Solute Carrier Family 25), which introduces a premature stop codon encoding a 95 amino acid polypeptide instead of 418 amino acids. Human SLC25A46 is an outer membrane protein and recent findings suggest a role in mitochondrial dynamics and cristae maintenance. Mutations in the SLC25A46 gene have been recently identified in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia.The objectives of this study was the phenotypic characterization of the mutant mice and its correlation with the human pathology, the genetic confirmation of the causal mutation and the expression analysis of wild-type and mutant Slc25a46 gene in order to understand the pathophysiology of SLC25A46-induced diseases. The results of our histopathological analysis showed that mutant mice manifest the main clinical features identified in patients, such as cerebellar lesions and underdeveloped retinal ganglion cell dendrites, indicative of optic atrophy. Moreover, ataxic mice manifest a distinct immunological phenotype which is characterized by thymic and splenic hypoplasia. The absence of mature lymphocytes did not reverse the neurological symptoms, indicating that the immune system is not responsible for the ataxic phenotype. Furthermore, to genetically confirm the causality of the identified mutation in the Slc25a46 gene, we generated transgenic mice that carry the human hSLC25A46 transgene. The ataxic phenotype was completely reversed in the presence of the human transgene, confirming that the mutation in the Slc25a46 gene is responsible for the ataxic phenotype.The expression analysis of Slc25a46 both at mRNA and protein level showed a specific expression in the central nervous system (CNS) of wild-type mice. As regards the mutation, it does not seem to affect the mRNA but the protein levels as the mutant protein is undetectable in ataxic mice. Through western blot analysis in mitochondrial enriched samples and overexpression of the SLC25A46-EGFP protein in the N2A cell line, we confirmed the mitochondrial localization of wild-type mouse SLC25A46 protein. Overexpressing the mutant SLC25A46-EGFP protein in the same cell line, we observed that the 95 amino acid peptide can not be incorporated into the mitochondrial membrane. Further experiments revealed that the SLC25A46 mouse protein is a mitochondrial outer membrane protein, similar to the human homolog.As SLC25A46 protein localizes to mitochondria, we investigated whether its absence affects mitochondrial function. For this purpose, we applied several mitochondrial assays in primary cultures of wild-type and ataxic mice and in an induced knockdown system generated in the present study. Collectively, our results showed that the absence of the SLC25A46 protein did not affect dramatically the main mitochondrial parameters. These results are consistent with the corresponding studies in human patients. Proteomic analysis in mitochondrial enriched samples of brain, cerebellum and liver from wild-type and ataxic mice, revealed that ablation of SLC25A46 protein in the cerebellum of ataxic mice affected remarkably the levels of proteins involved in mitochondrial dynamics and cristae maintenance, which is probably related to pathogenetic mechanisms.The ataxic model studied in the present thesis is the first mouse model carrying a Slc25a46 mutation. The fact that mouse and human SLC25A46 proteins are highly conserved, along with the complete reversal of the phenotype by the human transgene and the identification of SLC25A46 mutations in patients, renders the ataxic model ideal for understanding the involved pathogenetic mechanisms as well as for the application of novel therapeutic approaches.
Degree
thesis:*- Grantor dc:publisher
- Agricultural University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Terzenidou, Maria-Eirini
- Τερζενίδου, Μαρία-Ειρήνη
Subjects
dc:subject × 15Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40553